{"papers":[{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Prez2026p5733,\n  title = {Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement},\n  author = {Pérez Rosal Sergio R. and Faber Sonya C.},\n  journal = {Psychedelics},\n  year = {2026},\n  doi = {10.1016/j.psyche.2026.100029},\n  url = {https://doi.org/10.1016/j.psyche.2026.100029},\n}\n","source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-19 01:20:13","last_checked_at":"2026-08-09 08:28:45","metadata_record_url":"https://psilocybin-research.com/publication.php?id=5733#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Albertyn2026p3113,\n  title = {Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model},\n  author = {Albertyn Christopher P. and Richard Jérémie and Shore Ron and Carlson Linda E.},\n  journal = {Psychedelics},\n  year = {2026},\n  doi = {10.1016/j.psyche.2026.100032},\n  url = {https://doi.org/10.1016/j.psyche.2026.100032},\n}\n","source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-01 11:03:46","last_checked_at":"2026-08-09 08:28:45","metadata_record_url":"https://psilocybin-research.com/publication.php?id=3113#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6061,"title":"Current perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.","authors":"Chiappini S, Maremmani AGI, Cavallotto C, Marrangone C, Amerio A, Lupi M, Pettorruso M, Martinotti G.","journal":"Expert opinion on pharmacotherapy","publication_date":"2026-11-13","publication_year":2026,"doi":"10.1080/14656566.2026.2761183","pubmed_id":"43002438","openalex_id":null,"source_url":"https://doi.org/10.1080/14656566.2026.2761183","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-10 02:20:04","last_checked":"2026-11-14 02:20:19","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Chiappini2026p6061,\n  title = {Current perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.},\n  author = {Chiappini S and Maremmani AGI and Cavallotto C and Marrangone C and Amerio A and Lupi M and Pettorruso M and Martinotti G.},\n  journal = {Expert opinion on pharmacotherapy},\n  year = {2026},\n  doi = {10.1080/14656566.2026.2761183},\n  url = {https://doi.org/10.1080/14656566.2026.2761183},\n  pmid = {43002438},\n}\n","source_record_id":"PMID:43002438","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1080/14656566.2026.2761183","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:43002438","source_url":"https://doi.org/10.1080/14656566.2026.2761183","doi":"10.1080/14656566.2026.2761183","pmid":"43002438","publication_date":"2026-11-13","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-10 02:20:04","last_checked_at":"2026-11-14 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6061#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":5994,"title":"Psilocybin enhances conditioned place preference learning in planarians.","authors":"Ellenbroek BA, Naylor B, Youn J.","journal":"Behavioural pharmacology","publication_date":"2026-11-13","publication_year":2026,"doi":"10.1097/fbp.0000000000000903","pubmed_id":"42860751","openalex_id":"https://openalex.org/W7221551731","source_url":"https://doi.org/10.1097/fbp.0000000000000903","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Mechanism of Action,Drug Interactions","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-13 01:20:06","last_checked":"2026-11-14 02:20:19","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Ellenbroek2026p5994,\n  title = {Psilocybin enhances conditioned place preference learning in planarians.},\n  author = {Ellenbroek BA and Naylor B and Youn J.},\n  journal = {Behavioural pharmacology},\n  year = {2026},\n  doi = {10.1097/fbp.0000000000000903},\n  url = {https://doi.org/10.1097/fbp.0000000000000903},\n  pmid = {42860751},\n}\n","source_record_id":"PMID:42860751","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1097/fbp.0000000000000903","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42860751","source_url":"https://doi.org/10.1097/fbp.0000000000000903","doi":"10.1097/fbp.0000000000000903","pmid":"42860751","publication_date":"2026-11-13","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-10-13 01:20:06","last_checked_at":"2026-11-14 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=5994#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":5746,"title":"Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease","authors":"National Institute on Aging (NIA)","journal":"ClinicalTrials.gov","publication_date":"2026-11-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07721467","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-24 01:25:24","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{National2026p5746,\n  title = {Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease},\n  author = {National Institute on Aging (NIA)},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07721467},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07721467","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07721467","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07721467","source_url":"https://clinicaltrials.gov/study/NCT07721467","doi":"","pmid":"","publication_date":"2026-11-13","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-24 01:25:24","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=5746#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6069,"title":"How Does Psilocybin Affect Daily Life Experience and Behavior? Protocol For a Multimethod Ambulatory Assessment Study Within a Clinical Trial of Psilocybin for Depression","authors":"Sutu, A.; Kaplan, D.; Raison, C. L.; Sauder, C. J.; Arconada Alvarez, S. J.; Pozzo, N. S.; Salako, Z.; Chen, Z. J.; Palitsky, R.","journal":"medRxiv","publication_date":"2026-11-12","publication_year":2026,"doi":"10.64898/2026.11.10.26367628","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.11.10.26367628","substance_tags":"psilocybin","topic_tags":"Depression,Wellbeing,Clinical Trial,Review Article,Observational Study,Drug Interactions","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-11-13 02:22:01","last_checked":"2026-11-14 02:20:37","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Sutu2026p6069,\n  title = {How Does Psilocybin Affect Daily Life Experience and Behavior? Protocol For a Multimethod Ambulatory Assessment Study Within a Clinical Trial of Psilocybin for Depression},\n  author = {Sutu and A.; Kaplan and D.; Raison and C. L.; Sauder and C. J.; Arconada Alvarez and S. J.; Pozzo and N. S.; Salako and Z.; Chen and Z. J.; Palitsky and R.},\n  journal = {medRxiv},\n  year = {2026},\n  doi = {10.64898/2026.11.10.26367628},\n  url = {https://doi.org/10.64898/2026.11.10.26367628},\n}\n","source_record_id":"DOI:10.64898/2026.11.10.26367628","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.11.10.26367628","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.11.10.26367628","source_url":"https://doi.org/10.64898/2026.11.10.26367628","doi":"10.64898/2026.11.10.26367628","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-13 02:22:01","last_checked_at":"2026-11-14 02:20:37","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6069#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6036,"title":"Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study","authors":"Åkesson M, Granqvist P, Johansson R, Gruneau Brulin J.","journal":"Frontiers in psychiatry","publication_date":"2026-11-12","publication_year":2026,"doi":"10.3389/fpsyt.2026.1924069","pubmed_id":null,"openalex_id":"https://openalex.org/W7224118297","source_url":"https://europepmc.org/article/PMC/PMC13752497","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Wellbeing","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-29 02:20:13","last_checked":"2026-11-14 02:20:19","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{kesson2026p6036,\n  title = {Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study},\n  author = {Åkesson M and Granqvist P and Johansson R and Gruneau Brulin J.},\n  journal = {Frontiers in psychiatry},\n  year = {2026},\n  doi = {10.3389/fpsyt.2026.1924069},\n  url = {https://europepmc.org/article/PMC/PMC13752497},\n}\n","source_record_id":"DOI:10.3389/fpsyt.2026.1924069","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://europepmc.org/article/PMC/PMC13752497","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.3389/fpsyt.2026.1924069","source_url":"https://europepmc.org/article/PMC/PMC13752497","doi":"10.3389/fpsyt.2026.1924069","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-10-29 02:20:13","last_checked_at":"2026-11-14 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6036#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":5684,"title":"The Effects of Psilocybin on Social Connectedness","authors":"Yale University","journal":"ClinicalTrials.gov","publication_date":"2026-11-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07693153","substance_tags":"psilocybin","topic_tags":"Emotional Processing","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-10 01:23:02","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Yale2026p5684,\n  title = {The Effects of Psilocybin on Social Connectedness},\n  author = {Yale University},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07693153},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07693153","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07693153","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07693153","source_url":"https://clinicaltrials.gov/study/NCT07693153","doi":"","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-10 01:23:02","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=5684#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":3601,"title":"Psilocybin With Intracranial Neural Sensing","authors":"Joshua Woolley, MD, PhD","journal":"ClinicalTrials.gov","publication_date":"2026-11-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06919640","substance_tags":"psilocybin","topic_tags":"Chronic Pain","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Joshua2026p3601,\n  title = {Psilocybin With Intracranial Neural Sensing},\n  author = {Joshua Woolley and MD and PhD},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT06919640},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT06919640","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06919640","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06919640","source_url":"https://clinicaltrials.gov/study/NCT06919640","doi":"","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-01 11:04:28","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=3601#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":3555,"title":"NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy","authors":"M.D. Anderson Cancer Center","journal":"ClinicalTrials.gov","publication_date":"2026-11-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07227909","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Wellbeing,Mystical Experience,Healthcare Workers,Toxicity","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{MD2026p3555,\n  title = {NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy},\n  author = {M.D. Anderson Cancer Center},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07227909},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07227909","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07227909","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07227909","source_url":"https://clinicaltrials.gov/study/NCT07227909","doi":"","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-01 11:04:28","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=3555#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":3490,"title":"A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder","authors":"COMPASS Pathways","journal":"ClinicalTrials.gov","publication_date":"2026-11-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07570654","substance_tags":"psilocybin","topic_tags":"PTSD,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{COMPASS2026p3490,\n  title = {A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder},\n  author = {COMPASS Pathways},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07570654},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07570654","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07570654","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07570654","source_url":"https://clinicaltrials.gov/study/NCT07570654","doi":"","pmid":"","publication_date":"2026-11-12","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-01 11:04:27","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=3490#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6068,"title":"From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.","authors":"Kim J, Fogaca MV, Munguba H, Pignatelli M, Platholi J, Woodburn SC, Ma 马振中 ZZ.","journal":"The Journal of neuroscience: the official journal of the Society for Neuroscience","publication_date":"2026-11-11","publication_year":2026,"doi":"10.1523/jneurosci.1198-26.2026","pubmed_id":"43015122","openalex_id":null,"source_url":"https://doi.org/10.1523/jneurosci.1198-26.2026","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-13 02:20:06","last_checked":"2026-11-14 02:20:20","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Kim2026p6068,\n  title = {From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.},\n  author = {Kim J and Fogaca MV and Munguba H and Pignatelli M and Platholi J and Woodburn SC and Ma 马振中 ZZ.},\n  journal = {The Journal of neuroscience: the official journal of the Society for Neuroscience},\n  year = {2026},\n  doi = {10.1523/jneurosci.1198-26.2026},\n  url = {https://doi.org/10.1523/jneurosci.1198-26.2026},\n  pmid = {43015122},\n}\n","source_record_id":"PMID:43015122","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1523/jneurosci.1198-26.2026","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:43015122","source_url":"https://doi.org/10.1523/jneurosci.1198-26.2026","doi":"10.1523/jneurosci.1198-26.2026","pmid":"43015122","publication_date":"2026-11-11","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-13 02:20:06","last_checked_at":"2026-11-14 02:20:20","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6068#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6067,"title":"Exploring subacute effects of a DMT and harmine meditation retreat on the brain's control energy landscape","authors":"Llano Aristizabal, I.; Hefter, K.; Kulkarni, S. S.; Egger, K.; Scheidegger, M.; Tamir, D. I.; Bassett, D. S.","journal":"bioRxiv","publication_date":"2026-11-11","publication_year":2026,"doi":"10.64898/2026.11.07.764538","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.11.07.764538","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Default Mode Network,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-11-12 02:26:45","last_checked":"2026-11-14 02:22:02","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Llano2026p6067,\n  title = {Exploring subacute effects of a DMT and harmine meditation retreat on the brain's control energy landscape},\n  author = {Llano Aristizabal and I.; Hefter and K.; Kulkarni and S. S.; Egger and K.; Scheidegger and M.; Tamir and D. I.; Bassett and D. S.},\n  journal = {bioRxiv},\n  year = {2026},\n  doi = {10.64898/2026.11.07.764538},\n  url = {https://doi.org/10.64898/2026.11.07.764538},\n}\n","source_record_id":"DOI:10.64898/2026.11.07.764538","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.11.07.764538","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.11.07.764538","source_url":"https://doi.org/10.64898/2026.11.07.764538","doi":"10.64898/2026.11.07.764538","pmid":"","publication_date":"2026-11-11","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-12 02:26:45","last_checked_at":"2026-11-14 02:22:02","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6067#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":5745,"title":"The \"dark magic mushroom\" co-produces amatoxins and psilocybin.","authors":"Kunik AR, Christopher MW, Lemmond B, Dentinger BTM, Slot JC, Garrett TJ, Smith ME.","journal":"Current biology: CB","publication_date":"2026-11-11","publication_year":2026,"doi":"10.1016/j.cub.2026.10.041","pubmed_id":"43014316","openalex_id":null,"source_url":"https://doi.org/10.1016/j.cub.2026.10.041","substance_tags":"psilocybin","topic_tags":"Genomics","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-24 01:20:23","last_checked":"2026-11-14 02:20:19","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Kunik2026p5745,\n  title = {The \"dark magic mushroom\" co-produces amatoxins and psilocybin.},\n  author = {Kunik AR and Christopher MW and Lemmond B and Dentinger BTM and Slot JC and Garrett TJ and Smith ME.},\n  journal = {Current biology: CB},\n  year = {2026},\n  doi = {10.1016/j.cub.2026.10.041},\n  url = {https://doi.org/10.1016/j.cub.2026.10.041},\n  pmid = {43014316},\n}\n","source_record_id":"PMID:43014316","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.cub.2026.10.041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:43014316","source_url":"https://doi.org/10.1016/j.cub.2026.10.041","doi":"10.1016/j.cub.2026.10.041","pmid":"43014316","publication_date":"2026-11-11","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-24 01:20:23","last_checked_at":"2026-11-14 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=5745#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6066,"title":"A Placebo Cannot Be Psychedelic: Why psychedelic trials need dose, not mimicry, as their control","authors":"Liedtke W.","journal":"PsyArXiv","publication_date":"2026-11-10","publication_year":2026,"doi":"10.31234/osf.io/hkq53","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.31234/osf.io/hkq53","substance_tags":"psilocybin","topic_tags":"Pharmacology,Animal Study","study_type":"Clinical Trial","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-11-11 02:25:52","last_checked":"2026-11-14 02:20:19","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Liedtke2026p6066,\n  title = {A Placebo Cannot Be Psychedelic: Why psychedelic trials need dose, not mimicry, as their control},\n  author = {Liedtke W.},\n  journal = {PsyArXiv},\n  year = {2026},\n  doi = {10.31234/osf.io/hkq53},\n  url = {https://doi.org/10.31234/osf.io/hkq53},\n}\n","source_record_id":"DOI:10.31234/osf.io/hkq53","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://doi.org/10.31234/osf.io/hkq53","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/hkq53","source_url":"https://doi.org/10.31234/osf.io/hkq53","doi":"10.31234/osf.io/hkq53","pmid":"","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-11 02:25:52","last_checked_at":"2026-11-14 02:20:19","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6066#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6065,"title":"Psychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disorders","authors":"Gurgel Maria Luiza Góes, Ferreira Ana Luísa Carrijo, Mello Luisa da Costa, Caldato Amanda Comandolli, Canto Sofia Zaher do, Camilotti Pietra Brossi, Silva Manuela Ruela Folino, Gomes Raissa Assalin, Wiltemburg Beatriz Bomfim, Perini Giulia Spadone, Bertipaglia Manoela Rosa, Matos Rafaella Barcelos de, Orsi Enzo Seletti, Nacle Fernanda Oliveira, Ribeiro Gabriela Fernandes Daniel","journal":"International Health Sciences Review","publication_date":"2026-11-10","publication_year":2026,"doi":"10.70164/ihsr.v2i6.268","pubmed_id":null,"openalex_id":"https://openalex.org/W7225760100","source_url":"https://doi.org/10.70164/ihsr.v2i6.268","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-11-11 02:20:14","last_checked":"2026-11-14 02:20:23","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Gurgel2026p6065,\n  title = {Psychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disorders},\n  author = {Gurgel Maria Luiza Góes and Ferreira Ana Luísa Carrijo and Mello Luisa da Costa and Caldato Amanda Comandolli and Canto Sofia Zaher do and Camilotti Pietra Brossi and Silva Manuela Ruela Folino and Gomes Raissa Assalin and Wiltemburg Beatriz Bomfim and Perini Giulia Spadone and Bertipaglia Manoela Rosa and Matos Rafaella Barcelos de and Orsi Enzo Seletti and Nacle Fernanda Oliveira and Ribeiro Gabriela Fernandes Daniel},\n  journal = {International Health Sciences Review},\n  year = {2026},\n  doi = {10.70164/ihsr.v2i6.268},\n  url = {https://doi.org/10.70164/ihsr.v2i6.268},\n}\n","source_record_id":"DOI:10.70164/ihsr.v2i6.268","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.70164/ihsr.v2i6.268","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.70164/ihsr.v2i6.268","source_url":"https://doi.org/10.70164/ihsr.v2i6.268","doi":"10.70164/ihsr.v2i6.268","pmid":"","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-11 02:20:14","last_checked_at":"2026-11-14 02:20:23","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6065#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6064,"title":"Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients","authors":"Belinger Lydia, Moujaes Flora, von Rotz Robin, Rieser Nathalie M., Funk Xaver, Egger Klemens, Meinhold Lena, Renkert Maike, Stämpfli Philipp, Herdener Marcus, Vollenweider Franz X., Preller Katrin H.","journal":"Philosophical Transactions of the Royal Society B: Biological Sciences","publication_date":"2026-11-10","publication_year":2026,"doi":"10.1098/rstb.2025.0168","pubmed_id":"43007824","openalex_id":"https://openalex.org/W7225725324","source_url":"https://doi.org/10.1098/rstb.2025.0168","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-11-11 02:20:04","last_checked":"2026-11-14 02:20:23","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Belinger2026p6064,\n  title = {Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients},\n  author = {Belinger Lydia and Moujaes Flora and von Rotz Robin and Rieser Nathalie M. and Funk Xaver and Egger Klemens and Meinhold Lena and Renkert Maike and Stämpfli Philipp and Herdener Marcus and Vollenweider Franz X. and Preller Katrin H.},\n  journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},\n  year = {2026},\n  doi = {10.1098/rstb.2025.0168},\n  url = {https://doi.org/10.1098/rstb.2025.0168},\n  pmid = {43007824},\n}\n","source_record_id":"PMID:43007824","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1098/rstb.2025.0168","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:43007824","source_url":"https://doi.org/10.1098/rstb.2025.0168","doi":"10.1098/rstb.2025.0168","pmid":"43007824","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-11 02:20:04","last_checked_at":"2026-11-14 02:20:23","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6064#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":3585,"title":"Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter","authors":"NYU Langone Health","journal":"ClinicalTrials.gov","publication_date":"2026-11-10","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07296328","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Wellbeing,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{NYU2026p3585,\n  title = {Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter},\n  author = {NYU Langone Health},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07296328},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07296328","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07296328","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07296328","source_url":"https://clinicaltrials.gov/study/NCT07296328","doi":"","pmid":"","publication_date":"2026-11-10","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-07-01 11:04:28","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=3585#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":6062,"title":"Psilocybin for anorexia nervosa: efficacy, safety, and durability of clinical effects: a systematic review of clinical trials","authors":"Eskandar Kirolos, Shahat Kerolos","journal":"Debates em Psiquiatria","publication_date":"2026-11-09","publication_year":2026,"doi":"10.25118/2763-9037.2026.v16.1677","pubmed_id":null,"openalex_id":"https://openalex.org/W7225655046","source_url":"https://doi.org/10.25118/2763-9037.2026.v16.1677","substance_tags":"psilocybin","topic_tags":"Anxiety,Eating Disorders,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-11-10 02:20:12","last_checked":"2026-11-14 02:20:17","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Eskandar2026p6062,\n  title = {Psilocybin for anorexia nervosa: efficacy, safety, and durability of clinical effects: a systematic review of clinical trials},\n  author = {Eskandar Kirolos and Shahat Kerolos},\n  journal = {Debates em Psiquiatria},\n  year = {2026},\n  doi = {10.25118/2763-9037.2026.v16.1677},\n  url = {https://doi.org/10.25118/2763-9037.2026.v16.1677},\n}\n","source_record_id":"DOI:10.25118/2763-9037.2026.v16.1677","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.25118/2763-9037.2026.v16.1677","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.25118/2763-9037.2026.v16.1677","source_url":"https://doi.org/10.25118/2763-9037.2026.v16.1677","doi":"10.25118/2763-9037.2026.v16.1677","pmid":"","publication_date":"2026-11-09","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-11-10 02:20:12","last_checked_at":"2026-11-14 02:20:17","metadata_record_url":"https://psilocybin-research.com/publication.php?id=6062#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}},{"id":5852,"title":"Psilocybin Recovery Intervention for Stopping Methamphetamine Use","authors":"Nicky Mehtani, MD, MPH","journal":"ClinicalTrials.gov","publication_date":"2026-11-09","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07756736","substance_tags":"psilocybin","topic_tags":"Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-12 01:27:30","last_checked":"2026-11-14 02:22:36","bibtex":"% Exported from Psilocybin Research Database\n\n% Database site: https://psilocybin-research.com\n\n% Research database: https://psilocybin-research.com/\n\n\n\n@article{Nicky2026p5852,\n  title = {Psilocybin Recovery Intervention for Stopping Methamphetamine Use},\n  author = {Nicky Mehtani and MD and MPH},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07756736},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07756736","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07756736","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07756736","source_url":"https://clinicaltrials.gov/study/NCT07756736","doi":"","pmid":"","publication_date":"2026-11-09","importer_version":"2.1.3","text_redistributed":false,"indexed_at":"2026-08-12 01:27:30","last_checked_at":"2026-11-14 02:22:36","metadata_record_url":"https://psilocybin-research.com/publication.php?id=5852#metadata","attribution_scope":"Original research authorship remains with the listed authors. The tracker aggregates metadata and derives discovery labels; indexing and checking do not constitute scientific validation or individual manual review."}}],"limit":25,"offset":0}